Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis
- PMID: 11690704
- DOI: 10.1016/s0168-8278(01)00185-4
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis
Abstract
Background/aims: The place of transjugular intrahepatic porto-systemic shunt (TIPS) for variceal haemorrhage uncontrolled by sclerotherapy and medical treatment is still undefined. To investigate the outcome of early salvage TIPS for active uncontrolled variceal haemorrhage, and to identify the factors associated with mortality.
Methods: Salvage TIPS was performed in 58 patients as soon as possible after the diagnosis of variceal bleeding refractory to the combination of sclerotherapy and of pharmacological therapy. Twenty-three variables were assessed prospectively to identify predictors of mortality within 60 days of the procedure.
Results: The haemorrhage was controlled in 52 of 58 patients (90%). Bleeding persisted in six of 58 patients (10%), and recurred in four patients (7%). Overall, 17 (29%) and 20 (35%) patients died within respectively 30 days and 60 days of TIPS: five patients died of persistent bleeding, two patients died of recurrent bleeding, and 13 patients died of terminal liver failure. The actuarial survival following salvage TIPS was 51.7% at 1 year. On multivariate analysis, independent predictors of early mortality were: the presence of sepsis (P=0.001), the use of catecholamines for systemic hemodynamic impairment (P=0.009), and the use of balloon tamponade (P=0.04). Neither a single factor, nor a combination of factors before TIPS allowed to predict mortality confidently in a given patient.
Conclusions: Early salvage TIPS is an effective treatment to stop active variceal bleeding refractory to sclerotherapy and pharmacological treatment. Pre-treatment prognostic determinants that correlate to mortality can not be used to predict the outcome in individual cases.
Comment in
-
Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?J Hepatol. 2001 Nov;35(5):658-60. doi: 10.1016/s0168-8278(01)00238-0. J Hepatol. 2001. PMID: 11690713 No abstract available.
-
Salvage tips for uncontrolled variceal bleeding.J Hepatol. 2002 Nov;37(5):703-4. doi: 10.1016/s0168-8278(02)00321-5. J Hepatol. 2002. PMID: 12399244 No abstract available.
Similar articles
-
Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.United European Gastroenterol J. 2022 Oct;10(8):874-887. doi: 10.1002/ueg2.12300. Epub 2022 Oct 10. United European Gastroenterol J. 2022. PMID: 36217553 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).Hepatology. 1998 Jan;27(1):48-53. doi: 10.1002/hep.510270109. Hepatology. 1998. PMID: 9425916 Clinical Trial.
-
Evaluation of clinical outcome and predictors of mortality in patients undergoing antegrade transvenous variceal embolization in adjunct to salvage transjugular intrahepatic portosystemic shunt for active uncontrolled gastric variceal bleeding.Br J Radiol. 2024 Nov 1;97(1163):1791-1798. doi: 10.1093/bjr/tqae141. Br J Radiol. 2024. PMID: 39120077
-
Transjugular intrahepatic portosystemic shunt for acute variceal bleeding in patients with viral liver cirrhosis: predictors of early mortality.AJR Am J Roentgenol. 2005 Oct;185(4):885-9. doi: 10.2214/AJR.04.0607. AJR Am J Roentgenol. 2005. PMID: 16177405
-
Transjugular intrahepatic portosystemic shunt for acute variceal gastrointestinal bleeding: Indications, techniques and outcomes.Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):745-55. doi: 10.1016/j.diii.2015.05.005. Epub 2015 Jun 17. Diagn Interv Imaging. 2015. PMID: 26094039 Review.
Cited by
-
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.Intern Emerg Med. 2020 Jan;15(1):37-48. doi: 10.1007/s11739-019-02252-8. Epub 2020 Jan 9. Intern Emerg Med. 2020. PMID: 31919780 Review.
-
Where does TIPS fit in the management of patients with cirrhosis?JHEP Rep. 2020 May 23;2(4):100122. doi: 10.1016/j.jhepr.2020.100122. eCollection 2020 Aug. JHEP Rep. 2020. PMID: 32671331 Free PMC article. Review.
-
Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.Dig Dis Sci. 2019 Jun;64(6):1419-1431. doi: 10.1007/s10620-018-5448-y. Epub 2019 Jan 25. Dig Dis Sci. 2019. PMID: 30684079 Review.
-
Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage.World J Gastroenterol. 2013 Oct 7;19(37):6131-43. doi: 10.3748/wjg.v19.i37.6131. World J Gastroenterol. 2013. PMID: 24115809 Free PMC article. Review.
-
Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.United European Gastroenterol J. 2022 Oct;10(8):874-887. doi: 10.1002/ueg2.12300. Epub 2022 Oct 10. United European Gastroenterol J. 2022. PMID: 36217553 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical